Abstract
Several lines of evidence have suggested a role of the GH/IGF-I axis in the regulation of hemochrome. Many studies have been carried out in GH deficient children and adults about this topic, reporting predominantly a positive effect of recombinant human GH (rhGH) on red series, with no action on serum leucocytes and platelets counts. The aim of this study was to assess the impact of GH deficiency (GHD) and of rhGH replacement on blood cells count in 17 pre-pubertal children with idiopathic isolated GHD (11 males and 6 females, aged 9.1 ±0.8 yr) and in 18 patients with adult-onset GHD (12 males and 6 females, aged 47.9±3.0 yr). Evaluation of absolute and SD score (SDS) values of red blood cells, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelets and white blood cells was performed at baseline and after 12 months of rhGH treatment (0.045±0.001 mg/kg bw/day and 4.2±0.5 μg/kg bw/day for children and adults, respectively). At baseline, all patients showed low IGF-I levels. Effectiveness of rhGH therapy was documented by significant increase in height SDS, height velocity and serum IGF-I levels in children. In adults, adequacy of rhGH was demonstrated by significant increase in serum IGF-I and significant decrease in body fat. At baseline, about 25% of patients (4 of 17 children and 4 of 18 adults) showed normochromic normocytic anemia, while the other indices were normal. In 7 of the 8 anemic patients, normal levels of hemoglobin were restored on rhGH, while no change in all the other indices was observed. In conclusion, rhGH therapy at physiological doses has no effect on erythropoiesis in GHD children and adults with normal blood cells count, while in patients with normochromic normocytic anemia rhGH is able to restore normal hemoglobin levels.
Similar content being viewed by others
References
Golde DW, Bersch N, Li CH. Growth hormone: species-specific stimulation of erythropoiesis in vitro. Science 1977, 196: 1112–3.
Clausters M, Chatelain P, Sultan C. Insulin-like growth factor I stimulates human erythroid colony formation in vitro. J Clin Endocrinol Metab 1987, 65: 78–82.
Merchav S, Silvian Drachsler I, Tatarsky I, Lake M, Skottner A. Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors I and II. J Clin Endocrinol Metab 1992, 74: 447–52.
Nagy E, Berczi I. Pituitary dependence of bone marrow function. Br J haematol 1989, 71: 457–62.
Kurtz A, Zapf J, Eckardt K, Clemons G, Froesch ER, Bauer C. Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc Natl Acad Sci USA 1988, 85: 7825–9.
Valerio G, Di Maio S, Salerno M, Argenziano A, Badolato R, Tenore A. Assessment of red blood cell indices in growth-hormone-treated children. Horm Res 1997, 47: 62–6.
Ardizzi A, Guzzaloni G, Grugni G, et al. The effect of GH on erythropoiesis in vivo. Minerva Endocrinol 1993, 18: 83–5.
Vihervuori E, Sibila I, Siimes MA. Increases in hemoglobin concentration and iron needs in response to growth hormone treatment. J Pediatr 1994, 125: 242–5.
Eugster EA, Fisch M, Walvoord EC, DiMeglio LA, Pescovitz OH. Low hemoglobin levels in children with in idiopathic growth hormone deficiency. Endocrine 2002, 18: 135–6.
Kotzmann H, Riedl M, Clodi M, et al. The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. Eur J Clin Invest 1996, 26: 1175–81.
Ten Have SMTH, van der Lely AJ, Lamberts SWJ. Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy. Clin Endocrinol (Oxf) 1997, 47: 565–70.
Christ ER, Cummings MH, Westwood NB, et al. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J Clin Endocrinol Metab 1997, 82: 2985–90.
Sonksen PH, Christiansen JS. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. Growth Hormone Research Society. Growth Horm IGF Res 1998, 8 (Suppl B): 89–92.
Tanner JM, Whitehouse RH, Cameron N. The method in practice: standards for skeletal maturity and bone age. In: Tanner JM, Whitehouse RH, Cameron N eds. Assessment of skeletal maturity and prediction of adult height (TW2 Method). 2nd ed. San Diego: Academic Press Inc. 1983, 9–21.
Ghigo E, Aimaretti G, Giannotti L, Bellone J, Arvat E, Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 1996, 134: 352–6.
Dallman PR. Blood and blood-forming tissues. In: Rudolph AM ed. Pediatrics. 17th ed. Norwalk: Appleton-Century-Crofts. 1982, 1036–8.
Cook JD. Clinical evaluation of iron deficiency. Semin Hematol 1982, 19: 6–18.
Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross validation study. Am J Clin Nutr 1988, 47: 7–14.
Pichard C, Kyle UG, Bracco D, et al. Reference values of fat-free and fat masses by bioelectrical impedance analysis in 3393 healthy subjects. Nutrition 2000, 16: 245–54.
Sohmiya M, Katu Y. Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anemic patients with adult GH deficiency. Clin Endocrinol (Oxf) 2001, 55: 749–54.
Thomopoulos P, Postel-Vinay MC, Testa U, Guyda HJ, Posner BI. Receptors for insulin-like peptides (ILAs) in rat reticulocytes and erythrocytes. Endocrinology 1981, 108: 1087–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergamaschi, S., Giavoli, C., Ferrante, E. et al. Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome. J Endocrinol Invest 29, 399–404 (2006). https://doi.org/10.1007/BF03344122
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344122